ArticleJournal of clinical pathology2024

PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study.

Federica Miglietta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.